Wells Fargo & Company »

Reshape Lifesciences shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Reshape Lifesciences (RSLS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Reshape Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Reshape Lifesciences held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reshape Lifesciences by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $34 183 0.19
2023-12-31 $24 101 0.25
2023-09-30 $7 24 0.33
2023-06-30 $31 21 1.48
2022-12-31 $20 3 6.67

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Wells Fargo & Company

Top funds holding Reshape Lifesciences

Virtu Financial
Vanguard Group
Tower Research Capital
BlackRock
Millennium Management
Goldman Sachs Group
Jane Street
Geode Capital Management
Two Sigma Securities
XTX Topco
Qube Research & Technologies
Wells Fargo & Company
Cornerstone Planning Group
Advisor Group Holdings
Group One Trading

View all funds holding Reshape Lifesciences